JP6738274B2 - アナプラズマ抗体を検出するためのペプチド、器具、および方法 - Google Patents

アナプラズマ抗体を検出するためのペプチド、器具、および方法 Download PDF

Info

Publication number
JP6738274B2
JP6738274B2 JP2016547569A JP2016547569A JP6738274B2 JP 6738274 B2 JP6738274 B2 JP 6738274B2 JP 2016547569 A JP2016547569 A JP 2016547569A JP 2016547569 A JP2016547569 A JP 2016547569A JP 6738274 B2 JP6738274 B2 JP 6738274B2
Authority
JP
Japan
Prior art keywords
peptide
amino acid
peptides
group
acid selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016547569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017505436A5 (enExample
JP2017505436A (ja
Inventor
ラジェッシュ ケイ． メーラ
ラジェッシュ ケイ． メーラ
ケニス ピー． アロン
ケニス ピー． アロン
デニス エム． ブライル
デニス エム． ブライル
アンドリュー ピー． ロジャース
アンドリュー ピー． ロジャース
ティモシー ピー． フォーサイス
ティモシー ピー． フォーサイス
ジェレミー ディー． ウォーカー
ジェレミー ディー． ウォーカー
クリスティーナ アール． キューシコ
クリスティーナ アール． キューシコ
Original Assignee
アバクシス， インコーポレイテッド
アバクシス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アバクシス， インコーポレイテッド, アバクシス， インコーポレイテッド filed Critical アバクシス， インコーポレイテッド
Publication of JP2017505436A publication Critical patent/JP2017505436A/ja
Publication of JP2017505436A5 publication Critical patent/JP2017505436A5/ja
Application granted granted Critical
Publication of JP6738274B2 publication Critical patent/JP6738274B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/29—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Richettsiales (o)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
JP2016547569A 2014-01-21 2015-01-21 アナプラズマ抗体を検出するためのペプチド、器具、および方法 Active JP6738274B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461929655P 2014-01-21 2014-01-21
US61/929,655 2014-01-21
US14/511,916 2014-10-10
US14/511,916 US9194870B2 (en) 2014-01-21 2014-10-10 Peptides, devices, and methods for the detection of Anaplasma antibodies
PCT/US2015/012187 WO2015112558A2 (en) 2014-01-21 2015-01-21 Peptides, devices, and methods for the detection of anaplasma antibodies

Publications (3)

Publication Number Publication Date
JP2017505436A JP2017505436A (ja) 2017-02-16
JP2017505436A5 JP2017505436A5 (enExample) 2018-03-01
JP6738274B2 true JP6738274B2 (ja) 2020-08-12

Family

ID=53544557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016547569A Active JP6738274B2 (ja) 2014-01-21 2015-01-21 アナプラズマ抗体を検出するためのペプチド、器具、および方法

Country Status (13)

Country Link
US (4) US9194870B2 (enExample)
EP (2) EP3096784B1 (enExample)
JP (1) JP6738274B2 (enExample)
KR (1) KR102559678B1 (enExample)
CN (1) CN105916518A (enExample)
AU (1) AU2015209461B2 (enExample)
BR (1) BR112016016737B1 (enExample)
CA (1) CA2933376C (enExample)
ES (1) ES2767183T3 (enExample)
HU (1) HUE047156T2 (enExample)
PL (1) PL3636277T3 (enExample)
PT (1) PT3096784T (enExample)
WO (1) WO2015112558A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013113000A2 (en) 2012-01-26 2013-08-01 Luc Montagnier Detection of dna sequences as risk factors for hiv infection
US9194870B2 (en) 2014-01-21 2015-11-24 Abaxis, Inc. Peptides, devices, and methods for the detection of Anaplasma antibodies
US9956123B2 (en) * 2016-03-02 2018-05-01 Alphal Engineering Technology Group, Inc. Anti-microbial balanced weave wearable undergarment and process therefore
US20190079087A1 (en) * 2016-03-09 2019-03-14 Dai Nippon Toryo Co., Ltd. Composition comprising gold nanoplates, for detecting test substance, and use of same
CN106324253A (zh) * 2016-08-12 2017-01-11 江苏泽成生物技术有限公司 一种梅毒螺旋体抗体测定试剂盒及其检测方法
BR102017002668A2 (pt) 2017-02-09 2018-10-30 Biotick Pesquisa E Desenvolvimento Tecnologico Ltda peptídeo híbrido, conjunto de peptídeos híbridos, composição, usos do peptídeo híbrido, método de induzir resposta imune e kits
CN107137060B (zh) * 2017-04-14 2019-11-05 同济大学 一种易代谢的金纳米球/鸡卵清蛋白复合纳米光声探针及其制备
JP7041491B2 (ja) * 2017-10-31 2022-03-24 田中貴金属工業株式会社 バイオアッセイのための検出剤及びそれを用いたシグナルの増幅方法
JP7258698B2 (ja) * 2019-09-06 2023-04-17 大日本塗料株式会社 粒状物質をイムノクロマトグラフィー法によって検出する方法及びそのためのキット
WO2024211899A1 (en) * 2023-04-07 2024-10-10 Fuller Laboratories Assay for recent tick bite
CN119555937B (zh) * 2025-01-26 2025-05-20 杭州奥泰生物技术股份有限公司 一种犬虫媒病五联抗体检测卡及其制备方法和试剂盒

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US5965702A (en) 1991-10-21 1999-10-12 Abbott Laboratories Borrelia burgdorferi antigens and uses thereof
US5618533A (en) 1992-02-11 1997-04-08 Yale University Flagellin-based polypeptides for the diagnosis of lyme disease
US5932220A (en) 1995-05-08 1999-08-03 Board Of Regents University Of Texas System Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov.
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
US6207169B1 (en) 1997-03-21 2001-03-27 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6403093B1 (en) 1997-03-21 2002-06-11 Mayo Foundation For Medical Education And Research Methods to detect granulocytic ehrlichiosis
US6231869B1 (en) 1997-03-21 2001-05-15 Corixa Corporation Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU734659B2 (en) 1997-04-25 2001-06-21 Aquila Biopharmaceuticals, Inc. Nucleic acids, proteins, and methods of use of granulocytic erhlichia
AU7256398A (en) 1997-04-25 1998-11-24 Aquila Biopharmaceuticals, Inc. Characterization of granulocytic ehrlichia and methods of use
EP1026949B1 (en) 1997-09-19 2010-09-15 The Ohio State University Research Foundation Outer membrane proteins of ehrlichia chaffeensis
US6436399B1 (en) 1998-04-09 2002-08-20 The Ohio State University Research Foundation Nucleic acid encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby
US6355777B1 (en) 2000-04-28 2002-03-12 Research Development Foundation P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
US20030194756A1 (en) 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
US7407770B2 (en) 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
EP1581638B1 (en) 2002-11-04 2007-09-05 Research Development Foundation P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof
US7304139B2 (en) 2003-10-28 2007-12-04 University Of Florida Research Foundation, Inc. Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same
US20060046310A1 (en) 2004-08-25 2006-03-02 Zong-Li Xia Amplification method for solid phase immunoassays
US7390626B2 (en) 2005-02-25 2008-06-24 Immunosciences Lab., Inc. Methods and kit for diagnosing tick borne illnesses
MX2007016189A (es) 2005-06-16 2008-03-10 Res Dev Foundation Ortologos de proteinas inmunoreactivas de ehrlichia canis y e. chaffeensis.
EP1895015B1 (en) 2005-06-17 2012-07-25 Instituto de Salud Carlos III Method and kit for the detection of bacterial species by means of dna analysis
WO2007133623A2 (en) 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
US7776618B2 (en) 2007-03-01 2010-08-17 Church & Dwight Co., Inc. Diagnostic detection device
US7507789B2 (en) 2007-04-09 2009-03-24 Idexx Laboratories, Inc. Detection of Anaplasma platys
WO2008137881A2 (en) 2007-05-04 2008-11-13 The Ohio State University Research Foundation Ehrlichia ewingii proteins, nucleic acids, and methods of their use
ES2327593B1 (es) 2007-06-29 2010-08-05 Instituto De Salud Carlos Iii Metodo de identificacion de especies bacterianas de los generos anaplasma/ehrlichia y bartonella.
US8158370B2 (en) 2007-11-27 2012-04-17 Idexx Laboratories, Inc. Anaplasma phagocytophilum (Aph) antigens and antibodies specific for Anaplasma
JP6110066B2 (ja) 2008-10-08 2017-04-05 アイデックス ラボラトリーズ インコーポレイテッドＩＤＥＸＸ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． アナプラズマ・ファゴサイトフィルム（Ａｐｈ）およびアナプラズマ・プラチス（Ａｐｌ）に特異的な抗体を検出するための組成物および方法
US8257938B2 (en) 2009-02-27 2012-09-04 Medical Diagnostic Laboratories, Llc Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum
WO2011063003A2 (en) 2009-11-17 2011-05-26 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
CA2781117C (en) * 2009-11-20 2019-05-28 Abaxis, Inc. Peptides, devices, and methods for the detection of ehrlichia antibodies
US8455211B2 (en) 2010-07-15 2013-06-04 Medical Diagnostic Laboratories, Llc Anaplasma translocated substrate-1 (ATS-1) and sero-detection of Anaplasma phagocytophilum
WO2012135701A2 (en) 2011-03-31 2012-10-04 The Ohio State University Compositions and methods for the detection of anaplasma platys
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
ES2668863T3 (es) 2012-10-11 2018-05-22 Abaxis, Inc. Péptidos, dispositivos y métodos para la detección de anticuerpos de Ehrlichia
US9194870B2 (en) 2014-01-21 2015-11-24 Abaxis, Inc. Peptides, devices, and methods for the detection of Anaplasma antibodies

Also Published As

Publication number Publication date
BR112016016737A2 (pt) 2017-10-03
US20160109457A1 (en) 2016-04-21
EP3636277A1 (en) 2020-04-15
US9194870B2 (en) 2015-11-24
PL3636277T3 (pl) 2025-09-29
WO2015112558A2 (en) 2015-07-30
CA2933376C (en) 2023-09-26
US20150204868A1 (en) 2015-07-23
KR20160108521A (ko) 2016-09-19
AU2015209461A1 (en) 2016-06-30
US11131675B2 (en) 2021-09-28
EP3096784B1 (en) 2019-11-20
US10330687B2 (en) 2019-06-25
US9702883B2 (en) 2017-07-11
EP3096784A2 (en) 2016-11-30
US20190277857A1 (en) 2019-09-12
PT3096784T (pt) 2020-01-21
HUE047156T2 (hu) 2020-04-28
ES2767183T3 (es) 2020-06-16
CA2933376A1 (en) 2015-07-30
CN105916518A (zh) 2016-08-31
KR102559678B1 (ko) 2023-07-27
JP2017505436A (ja) 2017-02-16
BR112016016737B1 (pt) 2024-01-02
WO2015112558A3 (en) 2015-09-03
EP3096784A4 (en) 2017-12-06
EP3636277B1 (en) 2025-07-02
AU2015209461B2 (en) 2019-08-22
US20170363639A1 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
US11573227B2 (en) Peptides and methods for the detection of Lyme disease antibodies
JP6738274B2 (ja) アナプラズマ抗体を検出するためのペプチド、器具、および方法
US10948487B2 (en) Peptides, devices, and methods for the detection of Ehrlichia antibodies
HK40018259A (en) Peptides, devices, and methods for the detection of anaplasma antibodies

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180117

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180117

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181219

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190315

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190517

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191002

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200204

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200706

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200717

R150 Certificate of patent or registration of utility model

Ref document number: 6738274

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250